0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Neurology | 
Original Contribution |  May 01, 2013
Sleep Quality and Preclinical Alzheimer Disease
Yo-El S. Ju, MD; Jennifer S. McLeland, MSW, MA; Cristina D. Toedebusch, BS; et al.
JAMA Neurol. 2013;70(5):587-593. doi:10.1001/jamaneurol.2013.2334.
INCLUDES: CME , Supplemental Content
JAMA | 
News From the Centers for Disease Control and Prevention |  May 01, 2013
Alzheimer Deaths Increased During the Previous Decade
JAMA. 2013;309(17):1767. doi:10.1001/jama.2013.4201.
JAMA Neurology | 
Viewpoint |  April 29, 2013 ONLINE FIRST
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Neurol. 2013;():1-2. doi:10.1001/jamaneurol.2013.1502.
JAMA Neurology | 
Observation |  April 22, 2013 ONLINE FIRST
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
JAMA Neurol. 2013;():1-5. doi:10.1001/2013.jamaneurol.393.
JAMA Neurology | 
Original Contribution |  April 15, 2013 ONLINE FIRST
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Matthew Harms, MD; Bruno A. Benitez, MD; Nigel Cairns, PhD; et al.
JAMA Neurol. 2013;():1-6. doi:10.1001/2013.jamaneurol.537.
INCLUDES: , Supplemental Content
JAMA | 
Editorial |  April 10, 2013
Genome-Wide Association Studies, Alzheimer Disease, and Understudied Populations
Robert L. Nussbaum, MD
JAMA. 2013;309(14):1527-1528. doi:10.1001/jama.2013.3507.
JAMA | 
Original Contribution |  April 10, 2013
Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4,and the Risk of Late-Onset Alzheimer Disease in African Americans
Christiane Reitz, MD, PhD; Gyungah Jun, PhD; Adam Naj, PhD; et al.
JAMA. 2013;309(14):1483-1492. doi:10.1001/jama.2013.2973.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Viewpoint |  April 08, 2013 ONLINE FIRST
The Complexity of Integrating Speed and Safety in Drug Development and Approval
R. Alta Charo, JD
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.7161.
JAMA Neurology | 
Original Contribution |  April 01, 2013
Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth Hormone
David J. Irwin, MD; Joseph Y. Abrams, MPH; Lawrence B. Schonberger, MD, MPH; et al.
JAMA Neurol. 2013;70(4):462-468. doi:10.1001/jamaneurol.2013.1933.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Original Contribution |  April 01, 2013
The Aging Brain and Cognition:  Contribution of Vascular Injury and Aβ to Mild Cognitive Dysfunction
Natalie L. Marchant, PhD; Bruce R. Reed, PhD; Nerses Sanossian, MD; et al.
JAMA Neurol. 2013;70(4):488-495. doi:10.1001/2013.jamaneurol.405.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
News From the Centers for Disease Control and Prevention  |  May 01, 2013
Alzheimer Deaths Increased During the Previous Decade
JAMA Neurology
Original Contribution  |  March 11, 2013
Sleep Quality and Preclinical Alzheimer Disease
Yo-El S. Ju, MD; Jennifer S. McLeland, MSW, MA; Cristina D. Toedebusch, BS; et al.
JAMA Neurology
Viewpoint  |  April 29, 2013
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Neurology
Observation  |  April 22, 2013
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems